Search results
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 3 days agoOpzelura cream 1.5% is approved for the topical treatment of non-segmental vitiligo in adult and...
Why Does the Keto Diet Cause a Skin Rash?
Verywell Health via Yahoo News· 6 days agoKeto rash, or prurigo pigmentosa, is a rare, inflammatory skin condition that causes a red, itchy rash with bumps that can look like a web. Here’s what...
Zoetis Inc. (NYSE:ZTS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 hours agoZoetis Inc. (NYSE:ZTS) Q1 2024 Earnings Call Transcript May 2, 2024 Zoetis Inc. beats earnings...
Gene expression analyses identify potential drivers of chronic allergic inflammation
Medical Xpress· 3 days agoCurrently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks· 15 hours agoFree Report) reported a loss of 69 cents per share in the first quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 73 cents. In the year-ago quarter, Kymera reported a ...
Incyte shares dip after earnings, guidance miss
Investing.com· 4 days agoIncyte (NASDAQ: INCY ) Corporation (NASDAQ:INCY), a global biopharmaceutical company, reported first-quarter earnings that fell short of Wall Street...
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoIncyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation...
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After...
Benzinga· 22 hours agoSAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based financial markets.
Report offers several reasons to take part in a clinical trial
Local 12 Cincinnati· 4 days agoA recent report from the National Institutes of Health shows lots of reasons to participate in a...
Earnings call: Kymera Therapeutics reports progress in drug development By Investing.com
Investing.com· 8 hours agoKymera Therapeutics, during their first quarter 2024 earnings call, provided a comprehensive update...